Peptide library

Ipamorelin: What Lakeland Readers Should Know

Also known as: Ipamorelin acetate, NNC 26-0161, GH secretagogue

Not reviewed by a licensed provider. Read our disclaimer

Last updated

At a glance

Type
Growth hormone secretagogue (ghrelin-receptor agonist)
Human evidence
Very limited human data Only small or early human studies exist.
FDA status
Not FDA-approved; on FDA's safety-risk list for outsourcing facilities (503B); 503A nomination withdrawn (as of May 14, 2026)
How it is given
Injection (human studies used an IV drip; products sold are usually injected under the skin)

Ipamorelin is often marketed for muscle, recovery, sleep and anti-aging. Very little human research exists, and none of it tested those goals. This page explains what is known, what FDA has said about its safety, and what to ask. It is general information, not advice for your situation.

What it is and how it works

Ipamorelin is a lab-made chain of five amino acids. It was first described in 1998 by researchers at a drug company.1 It belongs to a group called growth hormone secretagogues, meaning substances that prompt the body to release growth hormone.

It works on the receptor used by ghrelin, a hormone best known for signaling hunger. When this receptor in the brain and pituitary gland is switched on, the pituitary releases a pulse of the body’s own growth hormone.12 It cannot work in people whose pituitary cannot make growth hormone at all.2

Ipamorelin was designed to be “selective.” In pigs, it raised growth hormone without raising the stress hormones cortisol and ACTH, unlike the older peptides GHRP-2 and GHRP-6.1 That claim comes mainly from animal studies. It has not been tested head-to-head in people.

What the research shows (and where evidence is weak)

FDA reviewed the evidence in 2024 and found only two published human studies.2

  1. A small study of healthy men looked at how the body handles ipamorelin given by vein. Growth hormone rose in a single pulse and then fell to very low levels within hours.3
  2. A trial after bowel surgery. In 114 patients recovering from bowel surgery, ipamorelin by vein was compared with placebo (a dummy treatment). The main goal was faster return of gut function. People on ipamorelin did not recover significantly faster than people on placebo, and other measures also showed no significant difference.4 The drug’s development for this use was then stopped.2

A second, larger company trial of 320 people finished in 2014 but has never posted results.5

Key gaps:

  • No trials for wellness goals. No human trial has tested ipamorelin for muscle, fat loss, strength, sleep, recovery or aging.2
  • Wrong route. Every published human study gave it by vein. FDA found no human safety or effectiveness data for injections under the skin, which is how it is usually sold.2
  • No animal toxicity studies. FDA found no published studies on long-term toxicity, cancer, genetic damage or reproduction.2
  • Raising growth hormone is not a proven benefit. Where growth hormone itself was tested in healthy older adults, a review found small changes in body fat and lean mass, more side effects, and concluded it cannot be recommended as an anti-aging therapy.6

Clinics sometimes claim it works better when combined with CJC-1295. FDA quoted that kind of claim from a website as marketing. No trial supports it.2

FDA and regulatory status

Not approved. There is no FDA-approved drug containing ipamorelin, and it is not part of any approved drug.2

Compounding. As of FDA’s page dated April 22, 2026, ipamorelin acetate is still on FDA’s significant-safety-risk list (Category 2) for outsourcing facilities (503B), where it has been since September 29, 2023.7 For traditional pharmacies (503A), its nomination was withdrawn by the people who nominated it. It does not appear in any 503A category on FDA’s list updated May 14, 2026.78 The withdrawal is not an FDA clearance. Before it, FDA had published an evaluation recommending against adding ipamorelin to the list of substances pharmacies may compound.2 FDA still posts its safety concerns.7 Ask any provider how their product is legally sourced. Florida pharmacy and prescribing rules also apply; see are peptides legal in Florida?. See compounded vs. FDA-approved peptides.

“Research chemical” products. Ipamorelin is also sold online labeled “not for human use.” These products are not made to drug-quality standards. See research-chemical peptide risks.

Sport. The World Anti-Doping Agency’s 2026 Prohibited List names ipamorelin among growth hormone secretagogues that are banned at all times.9

Common side effects and safety

In the bowel-surgery trial, the study authors called ipamorelin well tolerated. But low potassium, trouble sleeping and high blood sugar at discharge were more common than with placebo. Serious side effects overall were similar in both groups.2

FDA’s public safety statement says a published study “identified serious adverse events including death when ipamorelin was administered intravenously.”7 FDA’s review explains that this refers to two patients in that trial who died after complications of cancer surgery. FDA says it is unclear whether the deaths were related to ipamorelin, but still sees them as a safety concern.2

FDA also notes:2

  • Injected peptides can trigger immune reactions, and no human data exist on this for ipamorelin.
  • Growth hormone products carry warnings about tumor risk, high blood sugar and diabetes, fluid retention and pancreatitis. FDA says there are not enough data to rule out similar concerns for ipamorelin.
  • Animal research raises open questions about effects on reward pathways in the brain and on early pregnancy. These have not been shown for ipamorelin.

Tell a licensed provider about any symptom that worries you.

Typical cost range

There is no FDA-approved product, so there is no official price. Cost depends on the source, whether it is combined with other peptides, and clinic fees for visits, lab work or memberships. Insurance usually does not cover it. Prices vary between clinics and pharmacies. Ask any provider for a written price breakdown before you start.

Our cost guide covers what to ask about pricing.

Questions to ask a provider

  • Ipamorelin is not FDA-approved. Where does your product come from, and how is that allowed under current FDA rules?
  • What human evidence supports using it for my goal?
  • Human studies gave it by vein. What is known about injections under the skin?
  • Will it be combined with other peptides? If so, why, and what evidence supports that?
  • What lab work, such as blood sugar, potassium and IGF-1, will you check before and during use?
  • Are there FDA-approved or better-studied options? See peptides vs. TRT and HRT.
  • What is the total cost, and what does it include? See how to vet a peptide clinic.

Footnotes

  1. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. doi:10.1530/eje.0.1390552. https://doi.org/10.1530/eje.0.1390552 ↩ ↩2 ↩3

  2. U.S. Food and Drug Administration. FDA briefing document, Pharmacy Compounding Advisory Committee meeting, October 29, 2024: evaluation of ipamorelin-related bulk drug substances for inclusion on the 503A bulk drug substances list. 2024. Accessed November 2026. https://www.fda.gov/media/182088/download ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13

  3. Gobburu JV, Agersø H, Jusko WJ, Ynddal L. Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharm Res. 1999;16(9):1412-1416. doi:10.1023/a:1018955126402. https://doi.org/10.1023/a:1018955126402 ↩

  4. Beck DE, Sweeney WB, McCarter MD; Ipamorelin 201 Study Group. Prospective, randomized, controlled, proof-of-concept study of the ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. Int J Colorectal Dis. 2014;29(12):1527-1534. doi:10.1007/s00384-014-2030-8. https://doi.org/10.1007/s00384-014-2030-8 ↩

  5. ClinicalTrials.gov. NCT01280344: Safety and efficacy of ipamorelin compared to placebo for the recovery of gastrointestinal function. Record updated 2017. Accessed November 2026. https://clinicaltrials.gov/study/NCT01280344 ↩

  6. Liu H, Bravata DM, Olkin I, et al. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med. 2007;146(2):104-115. doi:10.7326/0003-4819-146-2-200701160-00005. https://doi.org/10.7326/0003-4819-146-2-200701160-00005 ↩

  7. U.S. Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks. Content current April 22, 2026. Accessed November 2026. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks ↩ ↩2 ↩3 ↩4

  8. U.S. Food and Drug Administration. Bulk drug substances nominated for use in compounding under section 503A of the FD&C Act. Updated May 14, 2026. Accessed November 2026. https://www.fda.gov/media/94155/download ↩

  9. World Anti-Doping Agency. The Prohibited List (2026). Accessed November 2026. https://www.wada-ama.org/en/prohibited-list ↩

Frequently asked questions

Is ipamorelin FDA-approved?

No. There is no FDA-approved product containing ipamorelin, and it is not part of any approved drug.

Was ipamorelin removed from FDA's safety list?

Only partly. The pharmacy (503A) nominations were withdrawn by the people who made them, and FDA had already recommended against adding it. It is still on FDA's significant-safety-risk list for outsourcing facilities (503B).

Has ipamorelin been tested for muscle, sleep or anti-aging?

No. No human trial has tested it for muscle, fat loss, sleep or aging. Its only efficacy trial was for gut recovery after bowel surgery, and it did not work better than placebo.

How is ipamorelin different from sermorelin?

Both prompt the body to release growth hormone, but by different receptors. Sermorelin copies the brain hormone GHRH. Ipamorelin acts on the receptor for ghrelin, a hunger hormone.

Can athletes use ipamorelin?

No. The World Anti-Doping Agency names ipamorelin on its 2026 Prohibited List, banned at all times.

Questions? Talk to a licensed provider

See a free list of top rated clinics in Lakeland and Polk County, with their phone numbers and Google reviews. No one will call you.

Find a top rated provider
Find a top rated provider today